Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
An Oral Methylprednisolone Taper Within a Multimodal Analgesic Regimen After Total Knee Arthroplasty
NCT05097976Phase 4Recruiting
- Sponsor
- Rush University Medical Center
- Start
- Mar 2022
- Primary completion
- May 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Methylprednisolone taper with Placebo taper (2 arms). Primary endpoint: Opioid consumption at 1 week. Started Mar 2022; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05097976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05097976.